BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ARID1A, BAF250, 8289, ENSG00000117713, SMARCF1, C1orf4, BM029, B120, RP1-50O24_1, P270, BAF250a AND Treatment
32239 results:

  • 1. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation.
    Qiao W; Li J; Xiong Y; Zheng J; Jin R; Hu C
    J Cancer Res Clin Oncol; 2024 May; 150(5):241. PubMed ID: 38713414
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy and Safety of Radiation Segmentectomy with
    Sarwar A; Malik MS; Vo NH; Tsai LL; Tahir MM; Curry MP; Catana AM; Bullock AJ; Parker JA; Eckhoff DE; Nasser IA; Weinstein JL; Ahmed M
    Radiology; 2024 May; 311(2):e231386. PubMed ID: 38713023
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
    Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
    Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
    Yang CX; Pan YX; Ye F; Zhu XD; Xue J; Li X; Yuan ZG; Zhang L; Xu L; Chen YJ; Wang NY; Sun HC; Liu XF;
    Front Immunol; 2024; 15():1310239. PubMed ID: 38711515
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Applications of Pyrrole and Pyridine-based Heterocycles in cancer Diagnosis and treatment.
    Tyagi R; Yadav K; Srivastava N; Sagar R
    Curr Pharm Des; 2024; 30(4):255-277. PubMed ID: 38711394
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review.
    Chang JY; Ruff SM; Cloyd JM
    Chin Clin Oncol; 2024 Apr; 13(2):25. PubMed ID: 38711178
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion.
    Zhang Y; Zhang H; Xu H; Wang Y; Feng L; Yi F
    World J Surg Oncol; 2024 May; 22(1):122. PubMed ID: 38711095
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nanoparticle/Engineered Bacteria Based Triple-Strategy Delivery System for Enhanced Hepatocellular Carcinoma cancer Therapy.
    Yang M; Chen W; Gupta D; Mei C; Yang Y; Zhao B; Qiu L; Chen J
    Int J Nanomedicine; 2024; 19():3827-3846. PubMed ID: 38708180
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Predicting effect of anti-PD-1/PD-L1 inhibitors therapy for hepatocellular carcinoma by detecting plasma metabolite based on UHPLC-MS.
    Liu B; Shi J; Su R; Zheng R; Xing F; Zhang Y; Wang N; Chen H; Feng S
    Front Immunol; 2024; 15():1370771. PubMed ID: 38707906
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long-term survival after hepatic resection for colorectal liver metastases: a single-center study in Iran.
    Pourfaraji SM; Moghadam MN; Moradi AM; Shirmard FO; Mohammadzadeh N; Jafarian A
    BMC Surg; 2024 May; 24(1):131. PubMed ID: 38702645
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).
    Lacombe K; Moh R; Chazallon C; Lemoine M; Sylla B; Fadiga F; Le Carrou J; Marcellin F; Kouanfack C; Ciaffi L; Sartre MT; Sida MB; Diallo A; Gozlan J; Seydi M; Cissé V; Danel C; Girard PM; Toni TD; Minga A; Boyer S; Carrieri P; Attia A;
    Sci Rep; 2024 May; 14(1):10244. PubMed ID: 38702350
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy and safety of transarterial chemoembolization combined with targeted therapy and immunotherapy versus with targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Feng J; Zhao Y; Zhai L; Zhou J
    Medicine (Baltimore); 2024 May; 103(18):e38037. PubMed ID: 38701263
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors.
    Sun W; Yin X; Liu X; Wei J; Yu M; Li W; Ding X; Chen J
    Front Immunol; 2024; 15():1380477. PubMed ID: 38698848
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of TikTok videos on acute pancreatitis: content quality and reliability analysis.
    Mao T; Zhao X; Jiang K; Yang J; Xie Q; Fu J; Du B; Lei Z; Gao F
    BMC Public Health; 2024 May; 24(1):1216. PubMed ID: 38698404
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Predictive factors of 90-day mortality after curative hepatic resection for hepatocellular carcinoma: a western single-center observational study.
    Vaghiri S; Lehwald-Tywuschik N; Prassas D; Safi SA; Kalmuk S; Knoefel WT; Dizdar L; Alexander A
    Langenbecks Arch Surg; 2024 May; 409(1):149. PubMed ID: 38698255
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis.
    Tan N; Ngu N; Worland T; Lee T; Abrahams T; Freeman E; Hannah N; Gazelakis K; Madden RG; Lynch KD; Valaydon Z; Sood S; Dev A; Bell S; Thompson AJ; Ding JN; Nicoll AJ; Liu K; Pandya K; Gow P; Lubel J; Kemp W; Roberts SK; Majeed A
    Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38696372
    [TBL] [Abstract] [Full Text] [Related]  

  • 17.
    Waziri P; Auta R; Imam MU; Chindo BA; Ladan Z; Mohammed Z; Wayah S; Mohammed J; Tahir MI; Ahmad AE; Alhassan Y; Tyoapine D; Agbaji AS
    J Evid Based Integr Med; 2024; 29():2515690X241251558. PubMed ID: 38689490
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
    Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
    Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.
    Zeng TM; Jiang TY; Yang G; Cheng Z; Lou C; Wei W; Tao CJ; Hu S; Wang H; Cui XW; Tan YX; Dong LW; Wang HY; Yuan ZG
    Clin Transl Med; 2024 May; 14(5):e1675. PubMed ID: 38689424
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1612.